4 Einträge gefunden

1. Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy).

   1. Schilling, Georgia
   2. Bruweleit, Melanie
   3. Harbeck, N
   4. Thomssen, C
   5. Becker, K
   6. Hoffmann, R
   7. Villena, C

   2009 - Forschungsinformationssystem des UKE
2. Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416.

   1. Loges, Sonja
   2. Tinnefeld, Heike
   3. Metzner, Anja
   4. Jücker, Manfred
   5. Butzal, Martin
   6. Bruweleit, Melanie
   7. Fischer, Uta

   2006 - Forschungsinformationssystem des UKE
3. Molekularbiologische Analyse der Wirkung des Angiogeneseinhibitors SU6668 als Second-line Therapie im Rahmen einer Studie bei Patienten mit Multiplem Myelom, Biomolecular analysis of the effect of a antiangiogenic substance SU6668 as second-line therapy in myeloma patients – a randomised clinical trial

   1. Bruweleit, Melanie

   2006 - E-Dissertationen der UHH - frei zugänglich
4. Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival.

   1. Loges, Sonja
   2. Heil, Gerhard
   3. Bruweleit, Melanie
   4. Schoder, Volker
   5. Butzal, Martin
   6. Fischer, Uta
   7. Gehling, Ursula

   2005 - Forschungsinformationssystem des UKE